Litcius/Paper detail

Impact of SARS-CoV-2 exposure history on the T cell and IgG response

Roanne Keeton, Marius B. Tincho, Akiko Suzuki, Ntombi Benede, Amkele Ngomti, Richard Baguma, Masego V. Chauke, Mathilda Mennen, Sango Skelem, Marguerite Adriaanse, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Linda‐Gail Bekker, Glenda Gray, Ntobeko Ntusi, Wendy A. Burgers, Catherine Riou

2022Cell Reports Medicine48 citationsDOIOpen Access PDF

Abstract

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposures, from infection or vaccination, can potently boost spike antibody responses. Less is known about the impact of repeated exposures on T cell responses. Here, we compare the prevalence and frequency of peripheral SARS-CoV-2-specific T cell and immunoglobulin G (IgG) responses in 190 individuals with complex SARS-CoV-2 exposure histories. As expected, an increasing number of SARS-CoV-2 spike exposures significantly enhances the magnitude of IgG responses, while repeated exposures improve the number of T cell responders but have less impact on SARS-CoV-2 spike-specific T cell frequencies in the circulation. Moreover, we find that the number and nature of exposures (rather than the order of infection and vaccination) shape the spike immune response, with spike-specific CD4 T cells displaying a greater polyfunctional potential following hybrid immunity compared with vaccination only. Characterizing adaptive immunity from an evolving viral and immunological landscape may inform vaccine strategies to elicit optimal immunity as the pandemic progress.

Topics & Concepts

ImmunologyVaccinationImmune systemImmunityAntibodyCoronavirusVirologyAcquired immune systemMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyCoronavirus disease 2019 (COVID-19)DiseaseInternal medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies